Skip to search.
 TSX Up 0.21% TSX Ventures Up 1.43%

Incyte Corporation (INCY)

-NasdaqGS
90.21 Up 2.09(2.37%) 4:00PM EDT
|After Hours : 90.23 Up 0.02 (0.02%) 4:48PM EDT
Prev Close:88.12
Open:88.52
Bid:82.00 x 100
Ask:95.11 x 200
1y Target Est:93.07
Beta:0.595173
Next Earnings Date: 9-Aug-16INCY Earnings announcement
Day's Range:86.67 - 90.35
52wk Range:55.00 - 133.62
Volume:859,753
Avg Vol (3m):1,065,980
Market Cap:16.93B
P/E (ttm):363.75
EPS (ttm):0.25
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
INCYUp 2.37%16.93B
CELGUp 0.84%86.90B
AMGNUp 0.44%129.23B

Key Statistics

Forward P/E (1 yr):65.85
P/S (ttm):19.27
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :0.05
Quarterly EPS Est (Jun-16) :0.00
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):44.94

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Incyte Corporation focuses on the discovery, development, and commercialization of proprietary therapeutics in oncology. It offers JAKAFI for the treatment of myelofibrosis and polycythemia vera cancers. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback